Orchid Chemicals initiates process for restructuring its debt

24 Jun 2013 Evaluate

Orchid Chemicals and Pharmaceuticals has initiated the process of restructuring its debt due to continuing liquidity constraints and pressure on operations. Accordingly the company has made reference to the Corporate Debt Restructuring Cell (CDR Cell) through State Bank of India (SBI).

Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Orchid Pharma Share Price

749.00 -12.60 (-1.65%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×